Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 December 2019 | Story Nonsindiso Qwabe | Photo Barend Nagel
Victoria Read more
Victoria the mannequin has become a familiar face in Nursing classrooms

She has an uncanny ability to move her eyes towards the sound of voices in a room, her voice shrills and squeals when she's in pain, she throws in a Spanish word or two, and she releases bodily fluids just like a real human would. 

These are just some of the quirky characteristics that make up the new R1,76 million-rand birthing mannequin in the School of Nursing's Simulation Unit, who goes by the name Victoria. She weighs more than 80 kg and is almost 1,7 metres high. With features such as real eyelashes, eyebrows, and hair, you can't help but do a double take when you lay eyes on her. 

Students getting practical experience

While the unit has other mannequins used for training Nursing students in each year or their study, Simulation Coordinator from the School of Nursing in the Faculty of Health Sciences, Cecile Fourie, said Victoria was a major upgrade for the school because of her versatility. Victoria would further enhance the school's quality of teaching by training students in their final year of undergraduate studies as well as those pursuing their postgraduate studies, about the ins and outs of pregnancy and other female morbidities, Fourie said. 

"We try to make our scenarios as real and authentic as possible and we've seen how much our students have grown. Introducing Victoria to our pre- and postgraduate students will prepare them to be competent in clinical practice." 

Meet Victoria

So, what exactly can Victoria do? 

Fourie said while the other mannequins were made with screws that made them look robot-like, Victoria was made with silicone and given a clean finish to make her appear life-like. The other mannequins can only blink, but Victoria's eyes move around, she can speak Spanish and French, and she comes with five tummies for different medical scenarios. She has a normal tummy which acts as a closure, an operable tummy for caesarean delivery, a tummy that allows a breeched baby to be twisted and turned from the outside just before delivery, a contraction tummy used for normal vaginal delivery – which also allows Victoria to push, bleed, urinate, and release mineral oil which acts as amniotic fluid. The fifth tummy is postpartum haemorrhage, a condition that is common among South African mothers after delivery. 

"It’s so good that we get to train our students in such real, lifelike circumstances. Through Victoria we're going to try and do our part in lessening maternal deaths, which are so prominent in our country. She can act out all the abnormalities that take place in a real delivery, and she can also have other medical conditions such as a heart attack," Fourie said.



News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept